VU Medicinal Chemists develop Virtual Machine for Computer-Aided Drug Discovery
A team of cheminformatics and bioinformatics researchers from Vrije Universiteit Amsterdam, Radboud university medical center Nijmegen, BioAxis Research, and Netherlands eScience Center have developed a freely available virtual machine to enable computer-aided drug design.
The 3D-e-Chem consortium, led by Amsterdam Data Science Researcher Dr. Chris de Graaf (Division Medicinal Chemistry, VU Amsterdam), develops new cheminformatics technologies to improve the integration of chemical and biological data for the prediction of structural interactions between drug molecules and therapeutic protein targets. The computational drug discovery platform is currently applied to identify and optimize molecules that act on several proteins simultaneously (polypharmacology), while avoiding undesired side effects via interactions with off-target proteins.
The 3D-e-Chem software tools and virtual machine are described in a recent publication in the Journal of Chemical Modeling and Information and the computational building blocks (nodes) that enable researchers to design their own drug discovery workflows have been incorporated in KNIME, the leading open data analytics platform.
The ADS Thesis Awards aim to promote excellence in Data Science and AI from students at BSc and Master level. The Awards are open to students from all Amsterdam-based knowledge institutes.
On the 22nd of September LAB42 will host its Grand Opening from 15:00 onwards. LAB42 is an international hub for developing talent in the fields of digital innovation and AI. The building is the result of a partnership between the UvA, the municipality of Amsterdam and the business sector.
The UvA Data Science Centre, part of the University Library, is pleased to host its second yearly Data Science Day on the 13th of October 2022.